Next-Gen Incretin.

Retatrutide (10mg) is a multi-target triple agonist peptide engineered to hit GLP-1, GIP, and glucagon receptors. Designed to evaluate advanced weight loss and metabolic regulation, it delivers greater energy expenditure and appetite control in preclinical studies. High-purity lyophilized powder for laboratory research.